ProductLife Group Appoints Dr. James Burt as Chief Executive Officer
Dr. James Burt
You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media.
ProductLife Group (PLG), a global provider of consulting and outsourcing services for the life sciences industry, today announced the appointment of Dr. James Burt as Chief Executive Officer, effective March 2026.
Dr. Burt brings over 20 years of international leadership experience across the pharmaceutical value chain, including generics, biosimilars, orphan drugs and value-added medicines. He is recognized for leading global organizations, scaling operations and driving strategic transformation in complex healthcare environments.
Prior to joining PLG, Dr. Burt served as Group CEO of Pharmanovia, where he led a major transformation and delivered significant business growth. Earlier in his career, he spent more than a decade at Accord Healthcare, most recently as Executive Vice President for Europe, the Middle East and Africa, overseeing a €750 million P&L and managing a team of approximately 2,500 employees.
Dr. Burt holds a Ph.D. in Biochemical Engineering from the University of Birmingham and has served as Vice President of Medicines for Europe, as well as Chair of the Value-Added Medicines Group.
This leadership transition follows a period during which Shaun Chilton served as Executive Chairman, ensuring continuity and positioning the company for its next phase of development. He will continue to serve as Chairman alongside Dr. Burt.
“ProductLife Group has established itself as a trusted partner to the life sciences industry,” said Dr. Burt. “I am excited to join the organization and work alongside its teams to further advance its capabilities and continue delivering value to clients and patients worldwide.”
Dr. Burt’s appointment comes at a pivotal moment for PLG as the company continues to expand its global footprint and strengthen its capabilities across regulatory, clinical, quality and digital services, supporting pharmaceutical, biotechnology and medical device companies worldwide.
About ProductLife Group
ProductLife Group (PLG) is a global provider of consulting and outsourcing services for the life sciences industry, delivering end-to-end support across the entire product lifecycle. With a presence in over 150 countries, operations in more than 50 countries, and a team of over 2,000 professionals, PLG supports pharmaceutical, biotechnology, medical device, nutrition and cosmetics companies in accelerating innovation, ensuring compliance and improving patient outcomes.
Sources: GlobeNewswire
ProductLife Group (PLG), a global provider of consulting and outsourcing services for the life sciences industry, today announced the appointment of Dr. James Burt as Chief Executive Officer, effective March 2026.
Dr. Burt brings over 20 years of international leadership experience across the pharmaceutical value chain, including generics, biosimilars, orphan drugs and value-added medicines. He is recognized for leading global organizations, scaling operations and driving strategic transformation in complex healthcare environments.
Prior to joining PLG, Dr. Burt served as Group CEO of Pharmanovia, where he led a major transformation and delivered significant business growth. Earlier in his career, he spent more than a decade at Accord Healthcare, most recently as Executive Vice President for Europe, the Middle East and Africa, overseeing a €750 million P&L and managing a team of approximately 2,500 employees.
